Member Login - Renew Today
ASGCT's MISSION is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
ASGCT's STRATEGIC VISION is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
The International Journal of
Molecular and Cellular Therapeutics
Official Journal of the
American Society of Gene & Cell Therapy
2010 Impact Factor: 7.149
Current Issue - May 2012, vol. 20, no. 5
Editorial
In This Issue
Research Highlights
Online Manuscript Submission

Novel Parkinson's Treatment Reportedly Reverses Symptoms - CBS News
Thursday, April 26th, 2012
FDA Commissioner's Fellowship Program Accepting Applications - Deadline: May 25, 2012
Thursday, April 19th, 2012
Breakthrough: SHAPE Really Matters When it Comes to Short Hairpin RNAs - John J. Rossi, PhD
Wednesday, April 18th, 2012
Breakthrough: Treating Muscular Dystrophy with Membrane Resealing - Dongshend Duan, PhD
Friday, April 6th, 2012
Bone-marrow transplant reverses Rett syndrome in mice - Nature
Thursday, April 5th, 2012
